Skip to main content
. Author manuscript; available in PMC: 2013 Mar 18.
Published in final edited form as: Antivir Ther. 2011 Nov 18;17(2):313–320. doi: 10.3851/IMP1985

Figure 3. Distribution of NNRTIsa mutations in patients failing Efavirenz (n=49)or Nevirapine(n=22) -containing first-line antiretroviral regimens in the CIPRA-SAb study in South Africa.

Figure 3

The error bars represent the confidence intervals.

a NNRTI = non-nucleoside reverse transcriptase inhibitor.

b CIPRA-SA is the Comprehensive International Program of Research on AIDS-South Africa.